Free Trial

TriMas (NASDAQ:TRS) Issues FY 2024 Earnings Guidance

TriMas logo with Industrial Products background

TriMas (NASDAQ:TRS - Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 1.700-1.900 for the period, compared to the consensus estimate of 1.710. The company issued revenue guidance of -. TriMas also updated its FY24 guidance to $1.70-1.90 EPS.

TriMas Stock Down 8.1 %

TRS stock traded down $2.19 on Monday, hitting $24.87. 579,614 shares of the company's stock were exchanged, compared to its average volume of 265,259. The firm has a 50 day moving average price of $25.83 and a two-hundred day moving average price of $25.82. TriMas has a 12-month low of $22.45 and a 12-month high of $28.51. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.48 and a current ratio of 2.82. The stock has a market cap of $1.01 billion, a P/E ratio of 25.38 and a beta of 0.66.

TriMas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Tuesday, November 5th will be given a dividend of $0.04 per share. The ex-dividend date is Tuesday, November 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.64%. TriMas's dividend payout ratio is currently 16.33%.

Wall Street Analysts Forecast Growth

Separately, BWS Financial reaffirmed a "buy" rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, October 9th.

Read Our Latest Report on TriMas

TriMas Company Profile

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Further Reading

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Should you invest $1,000 in TriMas right now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines